Siemens has received 510 (k) marketing clearance from the Food and Drug Administration for Biograph mMR, a system to enable simultaneous whole-body acquisition of data from magnetic resonance and positron emission tomography imaging. This enables users to get a more complete diagnostic picture of soft tissue, cellular activity and metabolism at the same time.

Biograph mMR, the first such technology of its kind, according to Siemens, is particularly valuable for oncology and neurology applications. Initial implementations include two hospitals in Germany and Massachusetts General Hospital in Boston.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access